These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 17626366

  • 1. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
    Strobl JS, Cassell M, Mitchell SM, Reilly CM, Lindsay DS.
    J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
    [Abstract] [Full Text] [Related]

  • 2. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D.
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [Abstract] [Full Text] [Related]

  • 3. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
    Codd R, Braich N, Liu J, Soe CZ, Pakchung AA.
    Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
    Han SB, Lee JK.
    Arch Pharm Res; 2009 Apr; 32(4):613-24. PubMed ID: 19407980
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors.
    Shinji C, Maeda S, Imai K, Yoshida M, Hashimoto Y, Miyachi H.
    Bioorg Med Chem; 2006 Nov 15; 14(22):7625-51. PubMed ID: 16877001
    [Abstract] [Full Text] [Related]

  • 6. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells.
    Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM.
    Cancer Res; 2004 Dec 01; 64(23):8778-81. PubMed ID: 15574791
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F, Caby S, Oger F, Cosseau C, Capron M, Grunau C, Dissous C, Pierce RJ.
    Mol Biochem Parasitol; 2009 Nov 01; 168(1):7-15. PubMed ID: 19538992
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells.
    Dagtas AS, Edens RE, Gilbert KM.
    Int Immunopharmacol; 2009 Oct 01; 9(11):1289-97. PubMed ID: 19664724
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M.
    J Pharmacol Exp Ther; 2003 Nov 01; 307(2):720-8. PubMed ID: 12975486
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thiol-based SAHA analogues as potent histone deacetylase inhibitors.
    Suzuki T, Kouketsu A, Matsuura A, Kohara A, Ninomiya S, Kohda K, Miyata N.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3313-7. PubMed ID: 15149697
    [Abstract] [Full Text] [Related]

  • 16. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM, Westendorf JJ.
    J Bone Miner Res; 2005 Dec 21; 20(12):2254-63. PubMed ID: 16294278
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors.
    Lee S, Shinji C, Ogura K, Shimizu M, Maeda S, Sato M, Yoshida M, Hashimoto Y, Miyachi H.
    Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4895-900. PubMed ID: 17588744
    [Abstract] [Full Text] [Related]

  • 18. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
    Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I, Coombes RC.
    Clin Cancer Res; 2001 Apr 01; 7(4):971-6. PubMed ID: 11309348
    [Abstract] [Full Text] [Related]

  • 19. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM.
    Oncol Rep; 2005 Jun 01; 13(6):1139-44. PubMed ID: 15870934
    [Abstract] [Full Text] [Related]

  • 20. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K, Hong J, Zee O, Ohuchi K.
    Br J Pharmacol; 2004 Jul 01; 142(6):1020-30. PubMed ID: 15210580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.